📰 Amgen News
Page 34 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
May 26, 2024
Building a big dividend portfolio doesn't have to be complicated.
May 26, 2024
The gold rush for obesity medications just got a bit more intense.
May 26, 2024
Nations Financial Group Inc. IA ADV reduced its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,286 shares of the medical research company’s stock after selling 1,310 shares during the period. Nations Financial […]
May 26, 2024
Intech Investment Management LLC decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 30.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,005 shares of the medical research company’s stock after selling 13,112 shares during the period. Intech Investment […]
May 26, 2024
Linscomb & Williams Inc. reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 35,306 shares of the medical research company’s stock after selling 3,846 shares during the quarter. Linscomb & Williams […]
May 26, 2024
Godshalk Welsh Capital Management Inc. purchased a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 715 shares of the medical research company’s stock, valued at approximately $206,000. Other hedge funds also recently made changes to […]
May 26, 2024
Glassman Wealth Services boosted its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 864 shares of the medical research company’s stock after purchasing an additional 95 shares during the period. Glassman Wealth […]
May 25, 2024
Primecap Management Co. CA lowered its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 14,591,468 shares of the medical research company’s stock after selling 140,990 shares during the quarter. Amgen comprises 3.3% of Primecap […]
May 25, 2024
USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in Antibody-Drug Conjugates (ADCs). From May 31 ...
May 24, 2024
Freedom Day Solutions LLC cut its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 1,672 shares of the medical research company’s stock after selling 63 shares during the quarter. Freedom Day Solutions LLC’s holdings in Amgen were worth $475,000 as of its most […]